Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 48 | 2023 | 16049 | 2.110 |
Why?
|
Receptor, ErbB-2 | 39 | 2017 | 2616 | 1.820 |
Why?
|
14-3-3 Proteins | 4 | 2016 | 143 | 1.790 |
Why?
|
Enhancer of Zeste Homolog 2 Protein | 2 | 2022 | 256 | 1.370 |
Why?
|
Brain Neoplasms | 10 | 2023 | 4995 | 1.340 |
Why?
|
Tumor Microenvironment | 9 | 2023 | 2980 | 1.250 |
Why?
|
Proto-Oncogene Proteins c-akt | 9 | 2017 | 2084 | 1.110 |
Why?
|
src-Family Kinases | 3 | 2015 | 480 | 1.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 28 | 2023 | 9064 | 1.020 |
Why?
|
Transforming Growth Factor beta | 3 | 2022 | 1141 | 1.010 |
Why?
|
Quinazolines | 7 | 2016 | 934 | 0.950 |
Why?
|
Drug Resistance, Neoplasm | 13 | 2021 | 5292 | 0.940 |
Why?
|
Cell Transformation, Neoplastic | 16 | 2020 | 2394 | 0.940 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2017 | 131 | 0.930 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 2 | 2013 | 29 | 0.860 |
Why?
|
Neoplasm Metastasis | 17 | 2017 | 5238 | 0.810 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2022 | 115 | 0.790 |
Why?
|
Adenovirus E1A Proteins | 11 | 2007 | 163 | 0.790 |
Why?
|
Histamine | 1 | 2021 | 54 | 0.790 |
Why?
|
Integrin beta1 | 1 | 2022 | 129 | 0.780 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 165 | 0.770 |
Why?
|
Immunotherapy | 6 | 2022 | 3480 | 0.770 |
Why?
|
Neoplasms | 14 | 2024 | 15696 | 0.740 |
Why?
|
Mice | 62 | 2024 | 35271 | 0.720 |
Why?
|
Antineoplastic Agents | 15 | 2022 | 14502 | 0.710 |
Why?
|
Animals | 78 | 2024 | 60933 | 0.710 |
Why?
|
Genes, erbB-2 | 7 | 2001 | 232 | 0.710 |
Why?
|
Cell Line, Tumor | 29 | 2023 | 14848 | 0.670 |
Why?
|
ErbB Receptors | 8 | 2015 | 2329 | 0.640 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 131 | 0.640 |
Why?
|
Antibodies, Monoclonal | 9 | 2022 | 4442 | 0.620 |
Why?
|
Trastuzumab | 11 | 2017 | 718 | 0.610 |
Why?
|
Signal Transduction | 15 | 2022 | 12133 | 0.610 |
Why?
|
Protein Kinase Inhibitors | 9 | 2017 | 4884 | 0.610 |
Why?
|
Bone Neoplasms | 4 | 2022 | 2652 | 0.600 |
Why?
|
Cancer Vaccines | 2 | 2022 | 727 | 0.580 |
Why?
|
Neoplasms, Experimental | 5 | 2017 | 749 | 0.580 |
Why?
|
L-Lactate Dehydrogenase | 2 | 2016 | 314 | 0.580 |
Why?
|
Mammary Neoplasms, Experimental | 4 | 2017 | 505 | 0.570 |
Why?
|
B7-H1 Antigen | 6 | 2022 | 1057 | 0.560 |
Why?
|
Proto-Oncogene Proteins | 11 | 1999 | 2547 | 0.550 |
Why?
|
Neuregulin-1 | 3 | 2001 | 83 | 0.550 |
Why?
|
Exosomes | 1 | 2019 | 258 | 0.540 |
Why?
|
Genetic Therapy | 11 | 2007 | 1630 | 0.510 |
Why?
|
Paclitaxel | 9 | 2001 | 2055 | 0.500 |
Why?
|
Phosphatidylinositol 3-Kinases | 5 | 2015 | 1706 | 0.490 |
Why?
|
Breast | 5 | 2017 | 1361 | 0.490 |
Why?
|
Triple Negative Breast Neoplasms | 3 | 2022 | 1295 | 0.490 |
Why?
|
Phosphorylation | 14 | 2022 | 4885 | 0.480 |
Why?
|
Antibodies, Monoclonal, Humanized | 10 | 2014 | 3362 | 0.480 |
Why?
|
Up-Regulation | 8 | 2016 | 2479 | 0.470 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2015 | 204 | 0.470 |
Why?
|
Genes, myc | 1 | 2015 | 360 | 0.460 |
Why?
|
Humans | 99 | 2024 | 270490 | 0.430 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2015 | 278 | 0.430 |
Why?
|
PTEN Phosphohydrolase | 5 | 2014 | 999 | 0.430 |
Why?
|
Genes, p53 | 7 | 2011 | 1122 | 0.430 |
Why?
|
Tumor Cells, Cultured | 27 | 2017 | 5509 | 0.420 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2015 | 1559 | 0.390 |
Why?
|
Protein Kinase C-alpha | 2 | 2014 | 66 | 0.380 |
Why?
|
Mice, Nude | 15 | 2021 | 4343 | 0.380 |
Why?
|
Adenoviridae | 6 | 2007 | 1455 | 0.380 |
Why?
|
Tumor Suppressor Protein p53 | 8 | 2019 | 3620 | 0.370 |
Why?
|
Female | 57 | 2023 | 147097 | 0.370 |
Why?
|
Enzyme Activation | 8 | 2012 | 1798 | 0.360 |
Why?
|
RNA, Long Noncoding | 3 | 2023 | 612 | 0.360 |
Why?
|
Transfection | 18 | 2001 | 2988 | 0.340 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 668 | 0.330 |
Why?
|
Mitogen-Activated Protein Kinases | 3 | 2001 | 656 | 0.330 |
Why?
|
T-Lymphocytes | 4 | 2023 | 3955 | 0.330 |
Why?
|
Mice, Transgenic | 7 | 2017 | 4228 | 0.330 |
Why?
|
Genes, ras | 2 | 2014 | 672 | 0.320 |
Why?
|
Blood-Brain Barrier | 2 | 2023 | 241 | 0.300 |
Why?
|
Proteomics | 2 | 2021 | 1422 | 0.300 |
Why?
|
Apoptosis | 12 | 2017 | 7755 | 0.290 |
Why?
|
Gene Expression | 10 | 2020 | 3593 | 0.290 |
Why?
|
Molecular Targeted Therapy | 2 | 2015 | 2371 | 0.280 |
Why?
|
Genetic Vectors | 6 | 2007 | 1712 | 0.280 |
Why?
|
Neoplasm Proteins | 6 | 2021 | 3288 | 0.280 |
Why?
|
Antineoplastic Agents, Phytogenic | 4 | 2001 | 881 | 0.270 |
Why?
|
Lung Neoplasms | 9 | 2019 | 11816 | 0.270 |
Why?
|
Tumor Escape | 2 | 2019 | 253 | 0.270 |
Why?
|
Neoplasm Transplantation | 10 | 2021 | 1532 | 0.260 |
Why?
|
Glycolysis | 3 | 2016 | 530 | 0.260 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 2006 | 98 | 0.260 |
Why?
|
Cell Line | 12 | 2021 | 5124 | 0.260 |
Why?
|
Dendritic Cells | 3 | 2022 | 1117 | 0.260 |
Why?
|
Cell Proliferation | 10 | 2023 | 7299 | 0.260 |
Why?
|
Neoplasm Invasiveness | 7 | 2019 | 4052 | 0.250 |
Why?
|
Neoplastic Stem Cells | 4 | 2021 | 1469 | 0.250 |
Why?
|
Hepatitis A Virus Cellular Receptor 2 | 2 | 2022 | 57 | 0.240 |
Why?
|
Brain | 4 | 2023 | 4186 | 0.230 |
Why?
|
Nuclear Proteins | 1 | 2015 | 3385 | 0.220 |
Why?
|
RNA, Small Nucleolar | 1 | 2023 | 25 | 0.220 |
Why?
|
Endothelial Growth Factors | 2 | 2001 | 223 | 0.220 |
Why?
|
NF-kappa B | 4 | 2019 | 1583 | 0.220 |
Why?
|
Oncogene Proteins, Viral | 3 | 2001 | 134 | 0.220 |
Why?
|
Transcription, Genetic | 5 | 2000 | 3146 | 0.220 |
Why?
|
Lymphokines | 2 | 2001 | 293 | 0.220 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2022 | 3930 | 0.220 |
Why?
|
Endothelium, Vascular | 2 | 2013 | 905 | 0.220 |
Why?
|
Receptors, Estrogen | 3 | 2017 | 2122 | 0.220 |
Why?
|
Sarcoma | 6 | 2001 | 1830 | 0.220 |
Why?
|
Lipolysis | 1 | 2023 | 113 | 0.220 |
Why?
|
Kynurenine | 1 | 2023 | 69 | 0.210 |
Why?
|
Carrier Proteins | 3 | 2019 | 2054 | 0.210 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2022 | 56 | 0.210 |
Why?
|
Cell Movement | 5 | 2022 | 2498 | 0.210 |
Why?
|
Oncogenes | 2 | 2019 | 677 | 0.210 |
Why?
|
Receptors, Eph Family | 1 | 2022 | 31 | 0.210 |
Why?
|
Cyclin-Dependent Kinase 9 | 1 | 2022 | 69 | 0.200 |
Why?
|
Receptors, Histamine | 1 | 2021 | 7 | 0.200 |
Why?
|
Soft Tissue Neoplasms | 3 | 2001 | 909 | 0.200 |
Why?
|
Casein Kinase II | 1 | 2022 | 62 | 0.200 |
Why?
|
Programmed Cell Death 1 Receptor | 4 | 2022 | 1069 | 0.200 |
Why?
|
Vitamin E | 1 | 2022 | 135 | 0.200 |
Why?
|
CDC2 Protein Kinase | 2 | 2001 | 180 | 0.200 |
Why?
|
Extracellular Matrix Proteins | 1 | 2023 | 312 | 0.200 |
Why?
|
RNA, Small Interfering | 2 | 2009 | 2221 | 0.200 |
Why?
|
Point Mutation | 3 | 2000 | 774 | 0.200 |
Why?
|
Carcinogenesis | 2 | 2021 | 1048 | 0.200 |
Why?
|
Ephrin-A4 | 1 | 2021 | 7 | 0.200 |
Why?
|
Leiomyosarcoma | 4 | 2000 | 248 | 0.200 |
Why?
|
Disease Progression | 5 | 2019 | 6888 | 0.190 |
Why?
|
Cyclin B1 | 2 | 2017 | 59 | 0.190 |
Why?
|
Proto-Oncogenes | 2 | 1992 | 202 | 0.190 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2021 | 55 | 0.190 |
Why?
|
Glucocorticoid-Induced TNFR-Related Protein | 1 | 2021 | 19 | 0.190 |
Why?
|
DNA Fingerprinting | 1 | 2021 | 172 | 0.180 |
Why?
|
Galectins | 1 | 2021 | 73 | 0.180 |
Why?
|
Immunity, Innate | 2 | 2024 | 702 | 0.180 |
Why?
|
Myocarditis | 1 | 2022 | 197 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2014 | 424 | 0.180 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2001 | 368 | 0.180 |
Why?
|
Extracellular Matrix | 1 | 2023 | 560 | 0.180 |
Why?
|
Nitrogen | 1 | 2020 | 178 | 0.170 |
Why?
|
RNA, Neoplasm | 3 | 2017 | 797 | 0.170 |
Why?
|
DNA Replication | 1 | 2024 | 747 | 0.170 |
Why?
|
Integrins | 1 | 2021 | 265 | 0.170 |
Why?
|
Cyclin-Dependent Kinases | 2 | 1998 | 321 | 0.170 |
Why?
|
Microfilament Proteins | 2 | 2019 | 498 | 0.170 |
Why?
|
Immunoenzyme Techniques | 2 | 2013 | 1183 | 0.170 |
Why?
|
Immunohistochemistry | 8 | 2022 | 7701 | 0.170 |
Why?
|
Immune Tolerance | 1 | 2021 | 408 | 0.170 |
Why?
|
Killer Cells, Natural | 2 | 2023 | 931 | 0.170 |
Why?
|
Ovarian Neoplasms | 7 | 2017 | 4730 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2014 | 518 | 0.160 |
Why?
|
Drug Resistance, Multiple | 2 | 1996 | 210 | 0.160 |
Why?
|
Disease Models, Animal | 7 | 2022 | 7415 | 0.160 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 208 | 0.160 |
Why?
|
CDC2-CDC28 Kinases | 1 | 1998 | 129 | 0.160 |
Why?
|
Antigen Presentation | 1 | 2019 | 283 | 0.160 |
Why?
|
Heterografts | 2 | 2021 | 749 | 0.150 |
Why?
|
Genes, p16 | 1 | 1998 | 132 | 0.150 |
Why?
|
HEK293 Cells | 4 | 2021 | 1512 | 0.150 |
Why?
|
Gene Targeting | 2 | 1998 | 298 | 0.150 |
Why?
|
Promoter Regions, Genetic | 7 | 2015 | 3104 | 0.150 |
Why?
|
G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 46 | 0.150 |
Why?
|
Adenoviruses, Human | 4 | 2000 | 176 | 0.150 |
Why?
|
Protein Array Analysis | 3 | 2021 | 504 | 0.150 |
Why?
|
Genes, Retinoblastoma | 2 | 1994 | 88 | 0.140 |
Why?
|
Cells, Cultured | 4 | 2013 | 5663 | 0.140 |
Why?
|
Cyclins | 1 | 1998 | 466 | 0.140 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2021 | 675 | 0.140 |
Why?
|
Down-Regulation | 6 | 2014 | 2113 | 0.140 |
Why?
|
MAP Kinase Signaling System | 1 | 2001 | 885 | 0.140 |
Why?
|
Transcription Factors | 4 | 2020 | 5360 | 0.140 |
Why?
|
Injections | 1 | 2017 | 288 | 0.140 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2021 | 1018 | 0.130 |
Why?
|
Protein Binding | 4 | 2021 | 3479 | 0.130 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2014 | 491 | 0.130 |
Why?
|
Fluorescent Antibody Technique | 2 | 2021 | 1079 | 0.130 |
Why?
|
Isoenzymes | 2 | 2016 | 633 | 0.130 |
Why?
|
Benzodioxoles | 1 | 2015 | 28 | 0.130 |
Why?
|
Neutrophils | 1 | 2020 | 845 | 0.130 |
Why?
|
Tissue Array Analysis | 1 | 2017 | 764 | 0.130 |
Why?
|
Indazoles | 1 | 2017 | 302 | 0.130 |
Why?
|
Retinoblastoma Protein | 2 | 1998 | 333 | 0.130 |
Why?
|
Zinc Finger Protein Gli2 | 1 | 2015 | 30 | 0.130 |
Why?
|
Glycoproteins | 1 | 1999 | 763 | 0.130 |
Why?
|
Macrophages | 1 | 2021 | 1372 | 0.120 |
Why?
|
Mice, Inbred BALB C | 5 | 2021 | 2401 | 0.120 |
Why?
|
Genes, Tumor Suppressor | 3 | 2001 | 1101 | 0.120 |
Why?
|
Peptide Hydrolases | 1 | 2016 | 257 | 0.120 |
Why?
|
Cell Cycle | 3 | 2013 | 2112 | 0.120 |
Why?
|
Smad Proteins | 1 | 2015 | 92 | 0.120 |
Why?
|
Sirtuins | 1 | 2014 | 43 | 0.120 |
Why?
|
Taxoids | 1 | 1998 | 994 | 0.120 |
Why?
|
Biopsy, Fine-Needle | 1 | 2017 | 699 | 0.120 |
Why?
|
Stem Cells | 2 | 2011 | 1242 | 0.120 |
Why?
|
Genes, Viral | 2 | 1997 | 201 | 0.120 |
Why?
|
Ubiquitination | 4 | 2019 | 579 | 0.110 |
Why?
|
Receptor, IGF Type 1 | 2 | 2013 | 350 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 2 | 2012 | 1876 | 0.110 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2014 | 131 | 0.110 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2015 | 198 | 0.110 |
Why?
|
Mutation | 9 | 2014 | 15577 | 0.110 |
Why?
|
Janus Kinase 2 | 1 | 2017 | 685 | 0.110 |
Why?
|
Imidazoles | 2 | 2014 | 1029 | 0.110 |
Why?
|
Cell Growth Processes | 1 | 2013 | 342 | 0.110 |
Why?
|
Electric Impedance | 1 | 2013 | 102 | 0.110 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2016 | 1589 | 0.110 |
Why?
|
Mice, SCID | 5 | 2021 | 1864 | 0.110 |
Why?
|
Ribonucleosides | 1 | 2012 | 40 | 0.110 |
Why?
|
Histones | 1 | 2020 | 1493 | 0.110 |
Why?
|
Protein Biosynthesis | 2 | 2015 | 913 | 0.110 |
Why?
|
Colonic Neoplasms | 1 | 2021 | 1429 | 0.110 |
Why?
|
Gene Knockout Techniques | 1 | 2013 | 278 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2012 | 1569 | 0.100 |
Why?
|
Gene Transfer Techniques | 1 | 1995 | 726 | 0.100 |
Why?
|
S-Phase Kinase-Associated Proteins | 1 | 2012 | 54 | 0.100 |
Why?
|
Sarcoma, Experimental | 3 | 2007 | 68 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2015 | 991 | 0.100 |
Why?
|
F-Box Proteins | 1 | 2012 | 102 | 0.100 |
Why?
|
Pancreatic Neoplasms | 2 | 2023 | 5227 | 0.100 |
Why?
|
Glucose | 2 | 2015 | 1267 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2023 | 1798 | 0.100 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 3836 | 0.100 |
Why?
|
Transcriptional Activation | 4 | 2009 | 1096 | 0.100 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2012 | 231 | 0.100 |
Why?
|
Cell Division | 8 | 2000 | 2553 | 0.100 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2011 | 696 | 0.090 |
Why?
|
Transglutaminases | 1 | 2011 | 101 | 0.090 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2013 | 229 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2016 | 1293 | 0.090 |
Why?
|
Transplantation, Heterologous | 6 | 2013 | 1091 | 0.090 |
Why?
|
Quinolines | 1 | 2014 | 396 | 0.090 |
Why?
|
Tyrosine | 3 | 2022 | 508 | 0.090 |
Why?
|
DNA-Binding Proteins | 4 | 2009 | 4907 | 0.090 |
Why?
|
Adenocarcinoma | 3 | 2021 | 7901 | 0.090 |
Why?
|
Glioblastoma | 1 | 2021 | 1844 | 0.090 |
Why?
|
Mammary Glands, Human | 1 | 2011 | 184 | 0.090 |
Why?
|
Receptor, trkB | 1 | 2010 | 53 | 0.090 |
Why?
|
GTP-Binding Proteins | 1 | 2011 | 325 | 0.090 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2001 | 343 | 0.090 |
Why?
|
MCF-7 Cells | 3 | 2017 | 551 | 0.090 |
Why?
|
Genomics | 1 | 2021 | 2817 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2017 | 1658 | 0.090 |
Why?
|
Immunoblotting | 1 | 2011 | 898 | 0.090 |
Why?
|
Blotting, Western | 3 | 2013 | 3595 | 0.080 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 649 | 0.080 |
Why?
|
Disease-Free Survival | 2 | 2019 | 10092 | 0.080 |
Why?
|
Peptidylprolyl Isomerase | 1 | 2009 | 73 | 0.080 |
Why?
|
3T3 Cells | 5 | 2001 | 366 | 0.080 |
Why?
|
Drug Synergism | 1 | 2012 | 1336 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6269 | 0.080 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2010 | 522 | 0.080 |
Why?
|
Phosphoproteins | 2 | 2011 | 1177 | 0.080 |
Why?
|
In Situ Hybridization | 1 | 2010 | 1059 | 0.080 |
Why?
|
Indoles | 2 | 2006 | 1021 | 0.080 |
Why?
|
Glycosylation | 2 | 2020 | 219 | 0.080 |
Why?
|
CTLA-4 Antigen | 1 | 2012 | 665 | 0.080 |
Why?
|
Models, Biological | 2 | 2011 | 3253 | 0.080 |
Why?
|
Interferon-gamma | 1 | 2012 | 1162 | 0.080 |
Why?
|
Sulfonamides | 1 | 2017 | 1896 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2011 | 16258 | 0.080 |
Why?
|
MicroRNAs | 2 | 2011 | 2954 | 0.080 |
Why?
|
Mesoderm | 1 | 2010 | 407 | 0.080 |
Why?
|
Prognosis | 4 | 2016 | 22229 | 0.080 |
Why?
|
Cell Survival | 4 | 2022 | 3061 | 0.070 |
Why?
|
Gene Knockdown Techniques | 3 | 2021 | 1082 | 0.070 |
Why?
|
Mice, Knockout | 3 | 2011 | 5793 | 0.070 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2012 | 1007 | 0.070 |
Why?
|
Chemotaxis | 3 | 2010 | 144 | 0.070 |
Why?
|
RNA Interference | 1 | 2011 | 1411 | 0.070 |
Why?
|
Mammary Glands, Animal | 1 | 2010 | 546 | 0.070 |
Why?
|
Sirolimus | 1 | 2011 | 834 | 0.070 |
Why?
|
Recombinant Proteins | 4 | 2001 | 2942 | 0.070 |
Why?
|
Carcinoma, Lobular | 1 | 2010 | 620 | 0.070 |
Why?
|
Cell Nucleus | 1 | 2002 | 1640 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2011 | 5531 | 0.070 |
Why?
|
Biomarkers, Tumor | 4 | 2016 | 10623 | 0.070 |
Why?
|
Base Sequence | 3 | 2021 | 4929 | 0.070 |
Why?
|
Epithelial Cells | 2 | 2010 | 1847 | 0.070 |
Why?
|
Receptors, Urokinase Plasminogen Activator | 1 | 2006 | 109 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2011 | 1007 | 0.070 |
Why?
|
Carbazoles | 1 | 2006 | 88 | 0.060 |
Why?
|
Protein Stability | 2 | 2016 | 374 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 5237 | 0.060 |
Why?
|
Lymphocyte Activation | 2 | 2023 | 1698 | 0.060 |
Why?
|
Tumor Stem Cell Assay | 2 | 1997 | 232 | 0.060 |
Why?
|
Cisplatin | 2 | 2011 | 2456 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 1179 | 0.060 |
Why?
|
Head and Neck Neoplasms | 2 | 2011 | 4073 | 0.060 |
Why?
|
Molecular Sequence Data | 4 | 1997 | 6123 | 0.060 |
Why?
|
Receptors, Progesterone | 1 | 2010 | 1415 | 0.060 |
Why?
|
MRE11 Homologue Protein | 1 | 2024 | 39 | 0.060 |
Why?
|
Oncolytic Virotherapy | 1 | 2007 | 257 | 0.060 |
Why?
|
GRB2 Adaptor Protein | 1 | 2024 | 54 | 0.060 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2001 | 238 | 0.060 |
Why?
|
Rad51 Recombinase | 1 | 2024 | 127 | 0.060 |
Why?
|
Neovascularization, Pathologic | 2 | 2001 | 1574 | 0.060 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2010 | 1228 | 0.060 |
Why?
|
Gelatinases | 2 | 1993 | 54 | 0.060 |
Why?
|
Ribonucleases | 1 | 2023 | 90 | 0.060 |
Why?
|
Liposomes | 2 | 1995 | 690 | 0.060 |
Why?
|
Positive Transcriptional Elongation Factor B | 1 | 2022 | 37 | 0.050 |
Why?
|
Rejuvenation | 1 | 2023 | 75 | 0.050 |
Why?
|
Nerve Growth Factors | 1 | 2022 | 108 | 0.050 |
Why?
|
Repressor Proteins | 1 | 1990 | 1698 | 0.050 |
Why?
|
Interleukin-15 | 1 | 2023 | 188 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2006 | 877 | 0.050 |
Why?
|
Adaptive Immunity | 1 | 2023 | 157 | 0.050 |
Why?
|
DNA | 3 | 2024 | 2735 | 0.050 |
Why?
|
Lymphatic Metastasis | 2 | 2010 | 4925 | 0.050 |
Why?
|
Estrogen Receptor beta | 1 | 2022 | 159 | 0.050 |
Why?
|
Antineoplastic Agents, Immunological | 2 | 2022 | 1313 | 0.050 |
Why?
|
Genes, MDR | 1 | 2001 | 42 | 0.050 |
Why?
|
DNA Fragmentation | 2 | 1998 | 199 | 0.050 |
Why?
|
THP-1 Cells | 1 | 2021 | 55 | 0.050 |
Why?
|
AC133 Antigen | 1 | 2021 | 114 | 0.050 |
Why?
|
Drug Resistance | 2 | 2000 | 600 | 0.050 |
Why?
|
Adipocytes | 1 | 2023 | 312 | 0.050 |
Why?
|
Adenovirus Early Proteins | 2 | 1991 | 9 | 0.050 |
Why?
|
Survival Rate | 2 | 2014 | 12429 | 0.050 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2022 | 318 | 0.050 |
Why?
|
Genomic Instability | 1 | 2024 | 524 | 0.050 |
Why?
|
Flavonoids | 1 | 2001 | 200 | 0.050 |
Why?
|
Jurkat Cells | 1 | 2021 | 315 | 0.050 |
Why?
|
Rats | 5 | 2007 | 6204 | 0.040 |
Why?
|
RNA, Messenger | 5 | 2001 | 6221 | 0.040 |
Why?
|
Protein Kinase C | 1 | 2001 | 397 | 0.040 |
Why?
|
Superoxide Dismutase | 1 | 2021 | 271 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 383 | 0.040 |
Why?
|
Flow Cytometry | 3 | 2007 | 3070 | 0.040 |
Why?
|
Cell Aggregation | 1 | 1999 | 59 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 1994 | 5465 | 0.040 |
Why?
|
Survival Analysis | 2 | 2021 | 9323 | 0.040 |
Why?
|
Sarcoma, Synovial | 1 | 2000 | 123 | 0.040 |
Why?
|
Plasmids | 2 | 1992 | 843 | 0.040 |
Why?
|
Estradiol | 1 | 2022 | 761 | 0.040 |
Why?
|
Kinetin | 1 | 1998 | 4 | 0.040 |
Why?
|
I-kappa B Proteins | 1 | 1999 | 175 | 0.040 |
Why?
|
Glutathione Transferase | 2 | 2011 | 367 | 0.040 |
Why?
|
Cyclin B | 1 | 1998 | 67 | 0.040 |
Why?
|
Receptor, ErbB-3 | 1 | 1999 | 126 | 0.040 |
Why?
|
Melanoma, Experimental | 1 | 2021 | 377 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2019 | 242 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 268 | 0.040 |
Why?
|
Phenotype | 4 | 2014 | 6395 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2022 | 503 | 0.040 |
Why?
|
U937 Cells | 1 | 2017 | 172 | 0.040 |
Why?
|
Antibodies | 1 | 2021 | 842 | 0.040 |
Why?
|
Oligonucleotides, Antisense | 1 | 1998 | 246 | 0.040 |
Why?
|
Tretinoin | 1 | 2000 | 637 | 0.040 |
Why?
|
NIH 3T3 Cells | 1 | 2017 | 264 | 0.040 |
Why?
|
Fibrosarcoma | 1 | 1997 | 135 | 0.040 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2022 | 867 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 1998 | 249 | 0.040 |
Why?
|
Caspases | 1 | 2000 | 685 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1998 | 531 | 0.040 |
Why?
|
Collagenases | 1 | 1997 | 77 | 0.040 |
Why?
|
Human Umbilical Vein Endothelial Cells | 1 | 2017 | 174 | 0.040 |
Why?
|
Purines | 1 | 1998 | 275 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 1998 | 203 | 0.040 |
Why?
|
Cross Reactions | 1 | 1997 | 271 | 0.040 |
Why?
|
Chloramphenicol O-Acetyltransferase | 2 | 1997 | 118 | 0.040 |
Why?
|
COP9 Signalosome Complex | 1 | 2016 | 73 | 0.040 |
Why?
|
Temperature | 1 | 1998 | 522 | 0.040 |
Why?
|
Vaccines, Subunit | 1 | 2017 | 126 | 0.040 |
Why?
|
Doxorubicin | 2 | 2001 | 3059 | 0.040 |
Why?
|
beta-Transducin Repeat-Containing Proteins | 1 | 2016 | 41 | 0.040 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 1997 | 171 | 0.040 |
Why?
|
Mice, Inbred ICR | 1 | 1997 | 243 | 0.030 |
Why?
|
Basement Membrane | 1 | 1997 | 142 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2022 | 822 | 0.030 |
Why?
|
Immunologic Surveillance | 1 | 2016 | 59 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2021 | 717 | 0.030 |
Why?
|
Glycogen Synthase Kinase 3 beta | 1 | 2016 | 166 | 0.030 |
Why?
|
Curcumin | 1 | 2016 | 117 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2019 | 480 | 0.030 |
Why?
|
HeLa Cells | 2 | 2014 | 1653 | 0.030 |
Why?
|
Sequence Alignment | 1 | 1997 | 847 | 0.030 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 1995 | 136 | 0.030 |
Why?
|
Epitopes | 1 | 1997 | 696 | 0.030 |
Why?
|
Fibroblasts | 2 | 1998 | 1689 | 0.030 |
Why?
|
Telomerase | 1 | 1998 | 547 | 0.030 |
Why?
|
Epidermal Growth Factor | 1 | 2016 | 427 | 0.030 |
Why?
|
Pyridines | 1 | 2001 | 1289 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 1506 | 0.030 |
Why?
|
Cell Adhesion | 1 | 1997 | 1016 | 0.030 |
Why?
|
Adenoma | 1 | 2019 | 732 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2001 | 1937 | 0.030 |
Why?
|
Trans-Activators | 1 | 2000 | 1624 | 0.030 |
Why?
|
DNA Primers | 1 | 1996 | 1421 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2014 | 236 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 1997 | 4278 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2001 | 5122 | 0.030 |
Why?
|
Pyrimidines | 1 | 2006 | 3603 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2010 | 4773 | 0.030 |
Why?
|
Pepsin A | 1 | 1992 | 16 | 0.030 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2013 | 156 | 0.030 |
Why?
|
Gene Amplification | 2 | 1993 | 745 | 0.030 |
Why?
|
beta-Galactosidase | 2 | 2007 | 220 | 0.030 |
Why?
|
Proteins | 1 | 2001 | 1986 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 472 | 0.030 |
Why?
|
Retroviridae Proteins, Oncogenic | 1 | 1992 | 39 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2001 | 2099 | 0.030 |
Why?
|
Cellular Senescence | 1 | 2014 | 386 | 0.030 |
Why?
|
Organelles | 1 | 2002 | 40 | 0.030 |
Why?
|
Cell Transformation, Viral | 1 | 1992 | 136 | 0.020 |
Why?
|
Male | 7 | 2022 | 127456 | 0.020 |
Why?
|
Cell Nucleolus | 1 | 2011 | 91 | 0.020 |
Why?
|
Middle Aged | 3 | 2021 | 89424 | 0.020 |
Why?
|
Young Adult | 1 | 2010 | 22102 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2011 | 200 | 0.020 |
Why?
|
RNA, Ribosomal | 1 | 2011 | 85 | 0.020 |
Why?
|
Entosis | 1 | 2011 | 4 | 0.020 |
Why?
|
Kisspeptins | 1 | 2011 | 15 | 0.020 |
Why?
|
CD24 Antigen | 1 | 2011 | 86 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 838 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2014 | 1502 | 0.020 |
Why?
|
Suppression, Genetic | 1 | 2011 | 67 | 0.020 |
Why?
|
Actins | 2 | 2007 | 614 | 0.020 |
Why?
|
Cytokinesis | 1 | 2011 | 57 | 0.020 |
Why?
|
Biomarkers | 1 | 2022 | 5172 | 0.020 |
Why?
|
Salvage Therapy | 2 | 2011 | 2095 | 0.020 |
Why?
|
Blotting, Southern | 1 | 1991 | 404 | 0.020 |
Why?
|
Oligopeptides | 1 | 2013 | 431 | 0.020 |
Why?
|
Obesity | 1 | 2023 | 2992 | 0.020 |
Why?
|
Cell Count | 1 | 2011 | 512 | 0.020 |
Why?
|
Hyaluronan Receptors | 1 | 2011 | 255 | 0.020 |
Why?
|
Oxamic Acid | 1 | 2009 | 2 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 1992 | 471 | 0.020 |
Why?
|
RNA | 2 | 2011 | 1030 | 0.020 |
Why?
|
Protein Transport | 1 | 2002 | 745 | 0.020 |
Why?
|
Aneuploidy | 1 | 2011 | 373 | 0.020 |
Why?
|
Heat Shock Transcription Factors | 1 | 2009 | 44 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2002 | 675 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2011 | 4162 | 0.020 |
Why?
|
NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2009 | 63 | 0.020 |
Why?
|
Enzyme Stability | 1 | 2009 | 108 | 0.020 |
Why?
|
Deoxyglucose | 1 | 2009 | 116 | 0.020 |
Why?
|
Everolimus | 1 | 2011 | 419 | 0.020 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2010 | 175 | 0.020 |
Why?
|
Lymph Node Excision | 1 | 1997 | 2015 | 0.020 |
Why?
|
Mitosis | 1 | 2011 | 623 | 0.020 |
Why?
|
Virus Replication | 2 | 2007 | 726 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2009 | 412 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 774 | 0.020 |
Why?
|
Genes, Reporter | 2 | 2000 | 809 | 0.020 |
Why?
|
Computational Biology | 1 | 2014 | 1298 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2009 | 620 | 0.020 |
Why?
|
Biological Transport | 1 | 2009 | 605 | 0.020 |
Why?
|
Aged | 2 | 2011 | 72809 | 0.020 |
Why?
|
Cell Lineage | 1 | 2011 | 699 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2009 | 590 | 0.020 |
Why?
|
Lactic Acid | 1 | 2009 | 310 | 0.020 |
Why?
|
Rats, Mutant Strains | 1 | 2007 | 23 | 0.020 |
Why?
|
Adult | 2 | 2011 | 80607 | 0.020 |
Why?
|
Ligands | 1 | 2010 | 1009 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 1997 | 6192 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2013 | 1253 | 0.020 |
Why?
|
Blotting, Northern | 2 | 2001 | 698 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2021 | 34185 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2013 | 1699 | 0.020 |
Why?
|
Perfusion | 1 | 2007 | 297 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 1514 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2006 | 296 | 0.020 |
Why?
|
Extremities | 1 | 2007 | 312 | 0.020 |
Why?
|
Oxygen | 1 | 2009 | 779 | 0.020 |
Why?
|
United States | 1 | 2022 | 16312 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2007 | 701 | 0.020 |
Why?
|
Cell Line, Transformed | 2 | 1997 | 397 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2021 | 4775 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2013 | 2210 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 2 | 2000 | 1595 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1990 | 1787 | 0.010 |
Why?
|
Carcinogenicity Tests | 1 | 2001 | 71 | 0.010 |
Why?
|
Cdc20 Proteins | 1 | 2001 | 26 | 0.010 |
Why?
|
Microscopy, Video | 1 | 2000 | 29 | 0.010 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2000 | 36 | 0.010 |
Why?
|
Consensus Sequence | 1 | 2000 | 114 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2011 | 4064 | 0.010 |
Why?
|
Growth Inhibitors | 1 | 2000 | 154 | 0.010 |
Why?
|
Injections, Intralesional | 1 | 2000 | 163 | 0.010 |
Why?
|
Survival | 1 | 2000 | 176 | 0.010 |
Why?
|
NF-KappaB Inhibitor alpha | 1 | 1999 | 138 | 0.010 |
Why?
|
Luciferases | 1 | 2000 | 454 | 0.010 |
Why?
|
Connective Tissue Cells | 1 | 1998 | 6 | 0.010 |
Why?
|
Caspase 3 | 1 | 2000 | 480 | 0.010 |
Why?
|
Connective Tissue | 1 | 1998 | 42 | 0.010 |
Why?
|
Rats, Nude | 1 | 1997 | 30 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2000 | 514 | 0.010 |
Why?
|
Technetium | 1 | 1997 | 77 | 0.010 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2001 | 611 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 1997 | 228 | 0.010 |
Why?
|
Femoral Vein | 1 | 1997 | 72 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 7734 | 0.010 |
Why?
|
Organ Specificity | 1 | 1998 | 701 | 0.010 |
Why?
|
beta Catenin | 1 | 2000 | 697 | 0.010 |
Why?
|
Femoral Artery | 1 | 1997 | 223 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1997 | 658 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2000 | 802 | 0.010 |
Why?
|
Binding Sites | 1 | 2000 | 2208 | 0.010 |
Why?
|
Phosphotyrosine | 1 | 1995 | 121 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2006 | 2914 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2001 | 2520 | 0.010 |
Why?
|
Sequence Deletion | 1 | 1997 | 880 | 0.010 |
Why?
|
In Vitro Techniques | 1 | 1995 | 1638 | 0.010 |
Why?
|
Moloney murine sarcoma virus | 1 | 1992 | 10 | 0.010 |
Why?
|
Oncogene Proteins v-mos | 1 | 1992 | 18 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1992 | 266 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1992 | 355 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1998 | 1328 | 0.010 |
Why?
|
China | 1 | 1992 | 626 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1992 | 1226 | 0.010 |
Why?
|
Liver | 1 | 1998 | 2989 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 1998 | 7153 | 0.000 |
Why?
|
Lung | 1 | 1998 | 3241 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2001 | 15189 | 0.000 |
Why?
|
Kidney | 1 | 1992 | 2196 | 0.000 |
Why?
|